Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01890707 · ClinicalTrials.gov registry record · NA
Intravenous Sedation Versus General Anesthesia in Patients Undergoing Minor Gynecologic Surgery
A NA study, sponsored by Northwestern University.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT01890707: Clinical Trial NA study, sponsored by Northwestern University.
NCT01890707 is a NA study that was terminated before completion, run by Northwestern University. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01890707, a NA study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The use of deep sedation may improve the quality of recovery of patients undergoing minor gynecologic procedures. These patients may also have shorter hospital stays and potentially lower healthcare costs. Additionally, the use of deep sedation for second trimester pregnancy termination may be associated with less bleeding, a smaller decrease in perioperative hemoglobin and better quality of recovery.
Primary Outcome
The patients self reported quality of recovery - 40 scores as completed 24 hours after the surgical procedure. 40 questions regarding the recovery of patients on a 1 poor-5 excellent scale. Total score on scale 40 (poor recovery)-200 (excellent recovery)
Interventions
- PROCEDURE General Anesthesia
- PROCEDURE Deep Sedation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2012-10-19 |
| Est. Completion | 2014-04-17 |
| Phase | NA |
Why NCT01890707 stopped before completion
NCT01890707 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which General Anesthesia is the first listed.
NCT01890707 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01890707 about?
NCT01890707 is a clinical study titled "Intravenous Sedation Versus General Anesthesia in Patients Undergoing Minor Gynecologic Surgery". The use of deep sedation may improve the quality of recovery of patients undergoing minor gynecologic procedures. These patients may also have shorter hospital stays and potentially lower healthcare costs. Additionally, the use of deep sedation for second trimester pregnancy termination may be assoc...
What is the current status of trial NCT01890707?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2012-10-19. Estimated completion is 2014-04-17.
What interventions are being tested in trial NCT01890707?
The interventions under investigation include: General Anesthesia (PROCEDURE), Deep Sedation (PROCEDURE).
Who is sponsoring clinical trial NCT01890707?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01890707's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI